Broad spectrum antibiotics can cause both transient and lasting damage to the ecology of the 18 gut microbiome. Loss of gut bacterial diversity has been linked to immune dysregulation and 19 disease susceptibility. Antibiotic-resistant populations of cells are known to arise spontaneously 20 in single-strain systems. Furthermore, prior work on subtherapeutic antibiotic treatment in 21 humans and therapeutic treatments in non-human animals have suggested that entire gut 22
antibiotic cefoperazone, independent of antibiotic treatment duration or xenobiotic dietary 27 amendment. These non-responder (i.e. resistant) microbiota were protected from biomass 28 depletion, transient ecological community collapse, and lasting diversity loss seen in the 29 susceptible microbiota. There were no major differences between non-responder microbiota and 30 untreated control microbiota at the community structure level. However, gene expression was 31 vastly different between non-responder microbiota and controls during antibiotic treatment, with 32 non-responder communities showing an upregulation of antimicrobial resistance genes and a 33 down-regulation of central metabolism. Thus, non-responder phenotypes appear to combat 34 antibiotic assault through a combination of efflux transporter upregulation and a reduced growth 35 rate across the entire gut community. Future work should focus on what factors are responsible 36 for tipping entire communities from susceptible to resistant phenotypes so that we might 37 harness this phenomenon to protect our microbiota from exposure to therapeutic antibiotic 38 treatment regimes.
Introduction 45
Despite the clear public health utility of antibiotics, there is an undeniable cost to their 46 widespread use in medicine and agriculture 1 . Antibiotic resistance in pathogens is on the rise 47 and evidence is mounting that antibiotic treatments cause damage to our commensal 48 microbiota 2-4 . The gut microbiome is an integral component of the human body, helping with 49 nutrient absorption, pathogen resistance, and immune system education 2 . When the ecology of 50 the gut is compromised by antibiotics, host health can suffer [5] [6] [7] . 51 Previous work in humans has shown that one round of antibiotic treatment can 52 temporarily alter the taxonomic composition of the gut microbiome, increase the prevalence of 53 antibiotic resistance genes, and lead to a permanent loss of species diversity [8] [9] [10] [11] [12] [13] [14] . The steady 54 decline of gut bacterial diversity in developed nations over the last century, likely due in part to 55 antibiotic use, has been implicated in the rise of chronic immune dysfunction 3,13,15 . Thus, finding 56 ways to prevent or mitigate the ecological damage done by antibiotics is an important public 57 health priority 13 . For example, strategies have been developed to introduce activated carbon 58 into the lower gut during antibiotic exposure to protect colonic bacteria 16 or to use autologous 59 fecal transplants to replenish gut diversity following treatment 17 . In addition to these therapeutic 60 strategies, the microbiome appears to exhibit natural antibiotic-resistance under certain 61 conditions. Sup-therapeutic doses of antibiotics in animal models have been shown to 62 substantially reduce gut microbiome diversity and biomass in some hosts but not others, 63
indicating that these communities vary in their capacity for resistance [18] [19] [20] . In single-strain 64 systems, sub-populations of antibiotic-resistant cells arise spontaneously due to stochastic 65 apportionment of efflux transporters between daughter cells 21, 22 or due to the spontaneous 66 amplification of antimicrobial resistance genes in mutant sub-populations 23 . Analogous 67 symmetry-breaking processes 21,22,24 may contribute to observed community-level antibiotic 68 resistance in the microbiome 18, 20 . 69
Heterogeneous responses of gut microbiota to therapeutic antibiotic treatments have 70 been reported in the literature 10, 18, 25, 26 . For example, while antibiotic exposure is a risk factor for 71
Clostridium difficile carriage and infection in hospitals, not all antibiotic-treated patients exposed 72 to C. difficile become infected 27,28 . To investigate this phenomenon in a controlled system, 73 Schubert et al. (2015) looked into how the type and concentration of antibiotic treatment 74 influenced C. difficile colonization of the murine gut 29 . The authors built a Random Forest (RF) 75 regression model that could accurately predict C. difficile colonization levels from the 76 composition of the gut microbiome. Cefoperazone, a broad-spectrum β -lactam antibiotic, had a 77 large effect on the composition of the gut microbiome across most mice, lowered bacterial 78 biomass by three orders of magnitude, and made mice susceptible to C. difficile colonization 79 and infection 29 . Interestingly, several mice that received relatively high concentrations of 80 cefoperazone were not colonized by the pathogen 29 . These resistant mice were also not 81 predicted to be colonized by the RF model and thus appeared to maintain a gut microbiome 82 similar in composition to the control mice. Based on these results, we hypothesized that whole-83 community antibiotic resistance to therapeutic levels of antibiotics might be a common 84 phenomenon in the mammalian gut. 85
In this study, we explore the potential mechanisms underlying the cefoperazone non-86 responder phenotype (i.e. cefoperazone resistant microbiomes) and look at how the prevalence 87 of this phenotype varies across treatment regimes. Although it was not a focus of their work, 88 Schubert et al. (2015) showed that the frequency of non-responder phenotypes decreased with 89 higher concentrations cefoperazone, 29 which comports with prior work on sub-therapeutic 90 antibiotic treatments in mice 18, 19 . Other important factors that could influence the frequency of 91 these non-responder phenotypes are the duration of antibiotic exposure 30 and host diet 31,32 . We 92 designed and carried out two independent mouse experiments to explore the reproducibility and 93 frequency of non-responder phenotypes to a therapeutic dose of cefoperazone (100-175 94 mg/kg/day) across duration and dietary treatments. For the diet experiment, we included a 1% 95 seaweed amendment to normal mouse chow, as used previously by our group 32 . We 96 hypothesized that previous exposures to plant-derived secondary compounds might influence 97 subsequent responses to antibiotics 33,34 , and raw seaweed is a rich source of these 98 compounds 35, 36 . In addition to measuring community composition and biomass, we sequenced 99 community transcriptomes in non-responder and control microbiomes to characterize the gene 100 expression profiles underlying community-wide resistance. 101
Overall, we found that 31% (i.e. 10 out of 32) of singly-housed mice exposed to 102 therapeutic levels of cefoperazone were protected from antibiotic-induced collapse of the gut 103 microbiome, independent of duration or dietary treatments. The community structure, species 104 diversity, and biomass of non-responder microbiomes were similar to untreated controls and 105 reproducible across both experiments. Despite little-to-no change in community composition, 106 non-responder microbiota showed dramatic differences in community transcriptional profiles 107 when compared to untreated mice (i.e. > 25% of all gene functions were differentially 108 expressed). Gene functions involved in growth and motility were downregulated and 109 antimicrobial resistance (efflux transporters, in particular) was upregulated in non-responder 110 microbiomes. Together, these results indicate that entire bacterial communities can 111 spontaneously protect themselves from collapse in the presence of a broad-spectrum antibiotic, 112 likely through a combination of quiescence and antimicrobial resistance. 113 114
Results and Discussion 115
Antibiotic duration experiment 116 28 week old female C57BL/6J mice from the same birth cohort were cohoused (5-6 mice per 117 cage) prior to beginning the experiment, and then separated into individual cages 1 week prior 118 to antibiotic treatments. Singly-housed mice were exposed to 0.5 mg/mL 29 cefoperazone in their 119 drinking water for 0, 2, 4, 8, or 16 days ( Fig. 1A ). C57BL/6J mice drink an average of 6 mL of 120 water each day 37 , so the dosage of cefoperazone was well within the therapeutic range (100-121 150 mg/kg/day). 16S amplicon sequencing showed the majority of cefoperazone-treated mice 122 experienced dramatic restructuring of their microbiome composition in response to antibiotics 123 reads were identified as being derived largely from mitochondria (likely from host) and 135 chloroplasts (likely from plant-based diet), respectively. Initially, we had predicted that duration 136 of exposure would be positively correlated with ASV extinction rates (i.e. ASVs present within a 137 mouse initially, but not at the end of the experiment). Treatment duration had no significant 138 effect on loss, gain (i.e. absent initially within a mouse, but present at the end of the 139 experiment), or persistence (i.e. present within a mouse at the beginning and end of the 140 experiment) of ASVs across the entire data set (ANOVA p > 0.1). There was a clear significant 141 increase in species extinctions and a decrease in persistent ASVs in antibiotic susceptible mice 142 compared to control mice ( Fig. 1D ). Non-responder mice, however, showed no significant 143 differences from controls in ASVs gained, lost, or persistent ( Fig. 1D ). Thus, non-responder 144 microbiota were protected from phylum-level collapse of gut bacterial community structure 145 following antibiotics and from antibiotic-associated diversity loss. 146 147 148 
161
Seaweed diet experiment 162 14 seven-week-old female C57BL/6J mice from the same birth cohort were cohoused prior to 163 beginning the experiment (5-6 mice per cage), and then separated into individual cages 1 week 164 prior to dietary treatments. Half of the mice were given a 1% seaweed in normal chow diet and 165 the other half received a normal chow diet for 20 days ( Fig. 2A ). All mice were put on a normal 166 chow diet for six days prior to antibiotic treatment. On day 26, all mice continued on a normal 167 chow diet and replicate mice from each dietary treatment group were given 0.5 mg/mL 168 cefoperazone in their drinking water for a period of 6 days ( Fig. 2A) . On most sampling days, 169 only the first three replicates from each treatment group were sampled for 16S sequencing. 170 k However, on the final day of antibiotic treatment, the full set of replicate mice were sampled (16 171 antibiotic-treated mice and 12 control mice). Seaweed treatment had a very minor impact on the 172 composition and diversity of the microbiome (Fig. S1) , similar to what we had observed 173 previously 32 . We found the same non-responder and responder phenotypes as in the duration 174 experiment, with 4 of the 16 mice exhibiting the non-responder phenotype (Fig. 2B-C) . The 175 seaweed diet had no effect on the frequency of the non-responder phenotype (Fisher's Exact 176
Test p = 1.0). We measured total 16S copy numbers for each sample (i.e. a proxy for bacterial 177 biomass) and found that antibiotic susceptible mice showed a dramatic drop in fecal bacterial 178 biomass following cefoperazone treatment, while non-responder microbiomes did not differ 179 significantly from controls in biomass levels ( Fig. 2D ). Similar to the first study, we saw an 180 enrichment in mitochondrial and chloroplast sequences in the susceptible mice, which also 181 corresponded to the drop in bacterial biomass ( Fig. 2D-E non-responder microbiota showed slightly lower alpha diversities than controls (Fig. 3A) . 203
Despite the resilience of Shannon diversity in the susceptible mice over time, only a small 204 number of these mice showed recovery in Bacteroidetes ASVs (Fig. 3B) . In control and non-205 responder mice, Bacteroidetes was the dominant phylum over the entire time series. However, 206
Firmicutes became the dominant phylum in responder mice following antibiotics and in many 207 mice there appeared to be a permanent loss of the Bacteroidetes phylum following recovery 208 ( Fig. 3B ). Seaweed dietary treatment appeared to contribute to a loss in resilience, with none of 209 the seaweed-fed susceptible mice showing recovery of the Bacteroides phylum ( Fig. S1) . 210
Post-antibiotics, the susceptible microbiomes were dominated by Firmicutes ( Figure 3B) . 211
In the diet experiment, in which mice were sampled on the last day of antibiotics and then 4 212 days post-antibiotics, most Firmicutes ASVs belonged to the order Clostridiales. In the duration 213 experiment, however, mice were sampled 2 days post-antibiotics. At the 2-day timepoint, some 214 Firmicutes populations were dominated by ASVs from the order Lactobacillales, while the rest 215 showed the familiar Clostridiales-dominated signature. By 4-days post-antibiotics, however, 216
Clostridiales had reached greater than 82% relative abundance in all mice, and the 217 Lactobacillales population had uniformly dwindled to less than 3.4% relative abundance. Thus, 218
Lactobacillales ASVs appear to be involved in rapid recovery following cessation of antibiotic 219 treatment, but are quickly displaced by Clostridiales ASVs. 220
Despite the fact that we saw no major differences in the gut microbiomes between 221 control diet (i.e. normal chow) mice and 1% seaweed-fed mice (Figs. 2C and S1), we did 222 observe a difference in mouse weight loss (Fig. 3C ). All antibiotic susceptible mice that were fed 223 seaweed showed a large, transient weight-drop a few days following the cessation of antibiotics 224 ( Fig. 3C ). Antibiotic-treated mice that did not receive seaweed also showed a mild drop in 225 weight, but the effect was weaker (Fig. 3C ). This weight loss phenotype was not observed in 226 control mice that were not treated with cefoperazone and was also not observed in antibiotic 227 non-responder mice from both diet treatment groups (Fig. 3C ). We do not have an explanation 228 for this synergistic effect between seaweed diet and cefoperazone treatment on transient weight 229 loss in mice, but we believe this to be an interesting research avenue to explore further. Non-responder microbiomes exhibit an antimicrobial resistance transcriptional program 242
To evaluate whether the occurrence of the non-responder phenotype might be associated with 243 changes in gene transcription in the gut, we performed RNA sequencing on samples from 10 244 d s ht mice before antibiotic treatment (days 20 and 25) and 7 mice during antibiotic treatment (day 245 29). Because there was close to no biomass in responder fecal samples after antibiotics 246 treatment, we compared non-responders to untreated controls on day 29. After RNA extraction, 247 ribosomal depletion, and sequencing to a mean of 20 million reads per sample, we identified 248 around 800,000 unique transcripts by de novo assembly (see Material and Methods) ranging 249 from 111 to >26,000 bp lengths (longer contigs were polycistronic; see Fig. S2 for length and 250 coverage distributions). Non-summarized transcript abundances were sufficient to distinguish 251 non-responder communities from controls after antibiotic treatment (Fig. 4A ). However, that may 252 be due to the high specificity of transcripts for each sample since we found that, on average, 253 each transcript only appeared in 3 of the 17 total samples (Fig. S3A) . Thus, we also also 254 assigned functional annotations to transcripts by aligning them to the M5NR database 38 . We 255 were able to assign 61% of the original transcripts to functions in the SEED subsystem 256 database 39 . This allowed us to collapse transcript counts for each sample into SEED functions, 257 which yielded a total of 53,877 unique functions. The majority of SEED functions were detected 258 in all 17 RNA-seq samples (see Fig. S3B ). Control and non-responder communities could be 259 easily distinguished by functional counts (see Fig. 4B ). In particular, about 45% of the variance 260 in functional expression could be explained by non-responder vs. control status (Euclidean 261 PERMANOVA p = 0.036) compared to only 6.7% of explained variance in 16S beta diversity 262 (Bray-Curtis PERMANOVA p = 0.027). Thus, transcriptional differences capture the non-263 responder phenotype much better than changes in community composition. 
275
After filtering out low abundance functions, differential expression testing between 276 controls and non-responder communities was performed for each of the three time points 277 sampled (see Materials and Methods). We observed that less than 5% of the observed 278 functions were differentially expressed at an FDR q ≤ 0.05 before antibiotic exposure (days 20 279 and 25), which fits our null-expectation. However, following antibiotic exposure (day 29), 27% of 280 all functions were differentially expressed between untreated controls and non-responder 281 communities (see Fig. 4C ). This indicated a global transcriptional shift in non-responder 282 microbiomes, mostly characterized by a up-regulation of several functional groups in the non-283 responder mice (blue dots on left side of Fig. 4C ). 284
The transcriptional program was most prominently characterized by an upregulation of 285 efflux transporters and other antibiotic resistance defense mechanisms, and a down-regulation 286 of motility and respiratory functions. For instance, the SEED sub-pathway "Transporters in 287
Models" was the most prominent subpathway in the differentially expressed functions, 288 containing 82 significant hits (FDR q ≤ 0.05). Most of the significantly upregulated functions in 289 the "Virulence, Disease and Defense" superpathway were also related to efflux pumps and their 290 al of ir regulation (Fig. 5A ). We also found large differences in of respiratory pathways, albeit with a 291 mixed pattern of up-and down-regulation (Fig. 5B) . The most striking respiratory difference we 292 observed was the down-regulation of three acetyl-CoA synthases which were some of the most 293 highly expressed functions in the untreated mice (Fig. 5E ). These pathways were down-294 regulated by one to two orders of magnitude in the non-responder mice, which suggests a 295 down-regulation of central metabolism. Additionally, we observed a consistent down-regulation 296 of flagellar motor proteins in the non-responder mice (Fig. 5C ). All differentially expressed 297 functions in the "Membrane Transport" superpathway were strongly upregulated in the non-298 responder mice, including components of TonB, which is known to be necessary for efflux 299 transporter function 40 (Fig. 5D ). Together, these data are consistent with previous reports that 300 upregulation of efflux transporters is accompanied by a concomitant reduction in growth 301 rate 21,41 . Finally, we observed the upregulation of the entire vancomycin resistance locus, 302
including the three efflux pumps Vex1-3 and the two-component system VncR and VncS (Fig.  303   5E ). The induction of vancomycin cross-resistance by β -lactams has been described before 42,43 304 and might indicate that these loci confer general efflux-based resistance to a range of 305 antibiotics. 306 We found that nearly one third of mice exposed to therapeutic levels of the 
Seaweed diet and antibiotic experiment 357
A new cohort of 28 mice were split randomly into two diet treatment groups and were fed with 358 either a custom chow diet (Bio-Serv, Flemington NJ) containing 1% raw seaweed nori (Izumi 359 Brand) or a standard control diet (product no. F3156; AN-93G; Bio-Serv, Flemington NJ). Prior 360 to the experiment, animals were co-housed for 10 days and then singly housed for 7 days prior 361 to separation into the seaweed treatment and control groups. After 20 days of dietary treatment, 362 all mice resumed the standard diet. From day 26 to day 31, 8 mice from each diet group were 363 administered 0.5 mg/mL cefoperazone in their drinking water as in the duration experiment. 364
Mice were weighed daily. Fresh fecal samples were obtained within an hour of one another 365 each day from all animals in all groups. Fecal samples were collected into anaerobic 40% 366 glycerol containing 0.1% cysteine and transferred immediately to dry ice before being stored at -367 80° C prior to nucleic acid extraction. Briefly, samples were homogenized with bead beating and then 50 μ L Proteinase K (QIAGEN) 374 added, and samples were incubated in a 65°C water bath for 10 min. Samples were then 375 incubated at 95°C for 10 min to deactivate the protease. 376
Amplicon sequencing library preparation and biomass quantification 377
Libraries for paired-end Illumina sequencing were constructed using a two-step 16S rRNA PCR 378 amplicon approach as described previously with minor modifications 44 . The first-step primers 379 (PE16S_V4_U515_F, 5′-ACACG ACGCT CTTCC GATCT YRYRG TGCCA GCMGC CGCGG 380 TAA-3′; PE16S_V4_E786_R, 5′-CGGCA TTCCT GCTGA ACCGC TCTTC CGATC TGGAC 381 TACHV GGGTW TCTAA T-3′) contain primers U515F and E786R targeting the V4 region of the 382 16S rRNA gene, as described previously 44 . Additionally, a complexity region in the forward 383 primer (5′-YRYR-3′) was added to help the image-processing software used to detect distinct 384 clusters during Illumina next-generation sequencing. A second-step priming site is also present 385 in both the forward (5′-ACACG ACGCT CTTCC GATCT-3′) and reverse (5′-CGGCA TTCCT 386 the Illumina adaptor sequences and a 9-bp barcode for library recognition (PE-III-PCR-F, 5′-388   AATGA TACGG CGACC ACCGA GATCT ACACT CTTTC CCTAC ACGAC GCTCT TCCGA  389   TCT-3′; PE-III-PCR- 
